Response to: 'Metering the METEOR in methotrexate failure: is propensity score a falling star?' by Ahmed
et al
Ann Rheum Dis
.
2019 Dec;78(12):e132.
doi: 10.1136/annrheumdis-2018-214652.
Epub 2018 Nov 14.
Authors
Sytske Anne Bergstra
1
,
Cornelia F Allaart
2
,
Robert B M Landewé
3
4
Affiliations
1
Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands s.a.bergstra@lumc.nl.
2
Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
3
Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands.
4
Department of Rheumatology, Zuyderland Medical Center, Heerlen, The Netherlands.
PMID:
30429121
DOI:
10.1136/annrheumdis-2018-214652
No abstract available
Keywords:
methotrexate; rheumatoid arthritis; treatment.
Publication types
Letter
Comment
MeSH terms
Antirheumatic Agents*
Arthritis, Rheumatoid*
Humans
Methotrexate
Propensity Score
Substances
Antirheumatic Agents
Methotrexate